Abstract
Multiple sclerosis (MS) is a chronic disease of the CNS that typically begins in late adolescence or early adulthood. It is highly variable in its expression and severity. The cause of MS is unknown, but both genetic and environmental factors have been implicated in its pathogenesis. It is known that viruses can induce chronic neurological disease, but the pathogenetic process in unclear. A viral cause for MS has been postulated, but to date no single virus has been confirmed to be associated with the disease. Although most viral candidates are no longer considered as possible aetiological agents in MS, a few are still being investigated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85(3): 311–8
Wucherpfenning KW, Strominger JL. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activated human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705
Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994; 76: 323–32
Lynch SG, Rose JW. Multiple sclerosis. Dis Mon 1996; 42(1): 1–55
Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand 1995; Suppl. 161: 23–33
Cook SD. Multiple Sclerosis and viruses. Mult Scler 1997; 3(6): 388–9
Kurtzke JF, Hyllested K, Heltberg A. Multiple sclerosis in the Faroe Islands: transmission across four epidemics. Acta Neurol Scand 1995; 91: 321–5
Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995; 45(8): 1554–60
Brown JS Jr. Geographic correlation of multiple sclerosis with tick-borne diseases. Mult Scler 1996; 1: 257–61
MacGregor HS, Latiwonk QI. Search for the origin of multiple sclerosis by first identifying the vector. Med Hypothesis 1992; 37: 67–73
Soldan SS, Berti R, Salem N. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997 Dec; 3(12): 1394–7
Cook SD, Rohowsky-Kochan C, Bansil S. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1995; Suppl. 161:34–42
Tytgat GN. Helicobacter pylori: causal agent in peptic ulcer disease? Conclusion. J Gastroenterol Hepatol 1991; 6(2): 139–40
Pachner AR, Duray P, Steere AC. Central nervous system manifestations of Lyme disease. Arch Neurol 1989 Jul; 46(7): 790–5
Gerber MA, Sedgwich AK, MacAlister TJ. The aetiological agent of cat scratch disease. Lancet 1985 Jun 1; 1(8440): 1236–9
Volker ter Meulen V, Katz M. The proposed viral aetiology of multiple sclerosis and related demyelinating diseases. In: Raine CS, Mc Farland HF, Tourtellotte WW, editors. Multiple sclerosis clinical and pathogenetic basis. Cambridge: Chapman & Hall, 1997:287–305
Pease LR, Murphy WH. Co-infection by lactic dehydrogenas virus and C-type retrovirus elicits neurological disease. Nature 1980; 286: 398–400
Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994; 36: S54–60
Osame M, Usuku K, Izumo S, et al. HTLVI associated myelopathy, a new clinical entity. Lancet 1986; II: 1031–2
Rice GP. Virus-induced demyelination in man: models for multiple sclerosis. Curr Opin Neurol Neurosurg 1992; 5(2): 188–94
Margulis MS, Soloviev VD, Shubladze AK. Aetiology and pathogenesis of acute sporadic disseminated encephalomyelitis and multiple sclerosis. J Neurol Neurosurg Psychiatry 1946; 9: 63–74
Bychkova EN. Viruses isolated from patients with encephalomyelitis and multiple sclerosis. I. Pathogenetic and antigenic properties. Fed Proc Transl 1965; Suppl. 24(4): 742–4
Field EJ, Miller H, Russel DS. Observation of glial inclusion bodies in case of acute disseminated sclerosis. J Clin Pathol 1962; 15: 278–84
GudnadottirM, HelgadottirH, Bjarnason O, et al. Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol 1964; 9: 85–95
Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol 1978; 24: 1–39
Carp RI, Licursi PC, Merz PA, et al. Decrease percentages of polimorphonuclear neutrophilis in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J Exp Med 1972; 136: 618–29
ter Meulen V, Koprowski H, Iwasaki Y, et al. Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsid and virion and isolation of parainfluenza-type virus. Lancet 1972; I: 1–5
Field EJ, Cowshall S, Narang HK, et al. Viruses in multiple sclerosis? Lancet 1972; II: 280–1
Cosby SL, McQuaid S, Taylor MJ, et al. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 1989; 70: 2027–36
Mitchell DN, Porterfield JS, Micheletti R, et al. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet 1978; II: 387–90
Wrobleska Z, Gilden D, Devlin M, et al. Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect Immun 1979; 25: 1008–15
Burks JS, Devald BL, Jankovsky LD, et al. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980; 209: 933–4
Melnick JL, Seidel E, Inoue YK, et al. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet 1982; I: 830–3
Vagabov RMA, Skortsoa TM, Gofman YP, et al. Isolation of the tick-borne encephalitis virus from a patient with multiple sclerosis. Acta Virol 1982; 26(5): 403
Koprowski H, DeFreitas EC, Harper ME, et al. Multiple sclerosis and human T cell lymphotropic retroviruses. Nature 1985; 318: 154–60
Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140: 551–61
Bergstrom T, Andersen O, Vahlne A. Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis. Ann Neurol 1989; 26: 283–5
Perron H, Suh M, Lalande B, et al. Herpes simplex virus ICPO and ICP4 immediate early proteins strongly enhance expression of a retrovirus harbored by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 1993; 74: 65–72
Munch M, Hvas J, Christensen T, et al. The implication of Epstein-Barr virus in multiple sclerosis — a review. Acta Neurol Scand 1997; Suppl 169: 59–64
Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpes virus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92: 7440–4
Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorecsence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993; 56: 917–9
Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci U S A 1997; 94:7583–8
Dalgleish AG. Viruses and multiple sclerosis. Acta Neurol Scand 1997; Suppl. 169: 8–15
Brahic M, Bureau JF. Multiple sclerosis and retroviruses. Ann Neurol 1997; 42: 984–5
Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoprolipherative disorders. Science 1986; 234(4776): 596–601
Yamanishi K, Okuno T, Shiraki M, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; I: 1065–7
Drobyski WR, Knox KK, Majewski D, et al. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med May 1994; 330(19): 1356–60
Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 69–73
Knox KK, Harrington DP, Carrigan DR. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995; 45: 288–92
Mackenzie IRA, Carrigan DR, Wiley CA. Chronic myelopathy associated with human herpesvirus-6. Neurology 1995; 45: 2015–7
Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170: 1586–9
He J, McCarthy M, Zhou Y, et al. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol Feb 1996; 1296–300
Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Disease 1995; 171: 273–80
Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis. Acta Neurol Scand 1997 May; 95(5): 280–3
Mayne M, Krishnan J, Metz L, et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol Sept 1998; 44(3): 391–4
Peters WP, Kufe D, Schlom J, et al. Biological and biochemical evidence for an interaction between Marek’s disease herpesvirus and avian leukosis virus in vivo. Proc Natl Acad Sci U S A 1973; 70: 3175–8
Chinnadurai G. Modulation of HIV-enhancer activity by heterologus agents: a mini review. Gene 1991; 101: 165–70
Sommerlund M, Pallesen G, Moller-Larsen A, et al. Retrovirus-like particles in an Epstein-Barr virus producing cell line derived rom a patient with chronic progressive myelopathy. Acta Neurol Scand 1993; 87: 71–6
IFNB Multiple Sclerosis Study Group. Interferon beta 1-b is effective in relapsing-remitting multiple sclerosis. Neurology 1993; 43: 655–61
Durelli L, Bongioanni MR, Cavallo R, et al. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology 1994; 44: 406–13
Lycke J, Svennerholm B, Hjelmquist, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. JNeurol 1996; 243: 214–24
Minis CA. Viral aetiology of diseases of obscure origin. Br Med Bull 1985; 41: 63–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berti, R., Jacobson, S. Role of Viral Infection in the Aetiology of Multiple Sclerosis. CNS Drugs 12, 1–7 (1999). https://doi.org/10.2165/00023210-199912010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-199912010-00001